Natarajan Vijayasankaran
Advertisement
Natarajan Vijayasankaran is engineer II at late stage cell culture, US Biologics Pharma Technical Development, Genentech, Inc.
Articles by Natarajan Vijayasankaran
Advertisement
Latest Updated Articles
Systematic Approaches to Develop Chemically Defined Cell Culture Feed MediaPublished: November 1st 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
2
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
3
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
4
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
5